For: | Perreault S, Nuevo J, Baumgartner S, Morlock R. Any link of gout disease control among hypertensive patients and onset of end-stage renal disease? Results from a population-based study. World J Nephrol 2017; 6(3): 132-142 [PMID: 28540203 DOI: 10.5527/wjn.v6.i3.132] |
---|---|
URL: | https://www.wjgnet.com/2220-6124/full/v6/i3/132.htm |
Number | Citing Articles |
1 |
Joanna Kedra, Bruno Fautrel. National reimbursement databases: Use and limitations for rheumatologic studies. Joint Bone Spine 2022; 89(5): 105369 doi: 10.1016/j.jbspin.2022.105369
|
2 |
Louise Roy, Michael Zappitelli, Brian White-Guay, Jean-Philippe Lafrance, Marc Dorais, Sylvie Perreault. Agreement Between Administrative Database and Medical Chart Review for the Prediction of Chronic Kidney Disease G category. Canadian Journal of Kidney Health and Disease 2020; 7 doi: 10.1177/2054358120959908
|
3 |
Ana Beatriz Vargas-Santos, Christine E. Peloquin, Yuqing Zhang, Tuhina Neogi. Association of Chronic Kidney Disease With Allopurinol Use in Gout Treatment. JAMA Internal Medicine 2018; 178(11): 1526 doi: 10.1001/jamainternmed.2018.4463
|
4 |
Jiayun Huang, Zheng Feei Ma, Ying Tian, Yeong Yeh Lee. Epidemiology and Prevalence of Gout in Mainland China: an Updated Systematic Review and Meta-Analysis. SN Comprehensive Clinical Medicine 2020; 2(9): 1593 doi: 10.1007/s42399-020-00416-8
|
5 |
Joanna Kedra, Bruno Fautrel. Bases de données nationales de remboursement : utilisation et limites dans le contexte des études de rhumatologie. Revue du Rhumatisme 2022; 89(5): 458 doi: 10.1016/j.rhum.2022.07.022
|